Your provider should discuss storage conditions specific to your prescribed compound
[Diagram suggestion: Flowchart starting with "Do you have T2D with A1C 7.0%?" branching left to "No Compounded semaglutide only option" and right to "Yes Check metformin trial" with subsequent decision nodes for plan tier, appeal decision, and savings card acceptance, ending in final recommendations.] FAQ Does Ambetter cover Ozempic for weight loss
In the case of MET-097i, it is a GLP-1 RA analog that has an extended half-life of ~15-16 days, which is many fold that of native GLP-1 peptide and more than 2x the half-life of semaglutide (GLP-1 RA)
Seeing GLP-1 present in the joint environment opens up the possibility that its role extends beyond metabolic pathways into local inflammatory modulation
Other common systemic side effects include constipation, diarrhea, headache, and fatigue
While the gastrointestinal effects (nausea, diarrhea, vomiting) are similar to other GLP-1 medications like Wegovy and Mounjaro, retatrutide has one unique finding: dysesthesia (abnormal touch sensations) in 20.9% of patients at the 12mg dose in TRIUMPH-4, and 12.5% at 12mg in the larger TRIUMPH-1 trial